Meerbusch/Geneva, 06.04.2016 – The German company dal33t GmbH from Meerbusch, which is specialized in Sync & Share Solutions, donated an additional set of PowerFolder Enterprise licenses to the Drugs for Neglected Diseases initiative (DNDi). Thus, the since 2014 existing cooperation of the cloud specialist with the non-profit organization from the healthcare sector will be further expanded. The additional licenses are rapidly needed by DNDi, especially for new studies in the Democratic Republic of the Congo (DRC), to add more clinical sites and staff.
The fight against neglected diseases needs a reliable Sync & Share Solution
DNDi develops safe, effective, and – most importantly – affordable drugs for neglected diseases. These include sleeping sickness, Chagas disease, leishmaniasis, paediatric HIV, filaria diseases, mycetoma, and hepatitis C. A billion people worldwide – including 500 million children – are suffering from these diseases, that are responsible for 90 percent of the global burden of disease although the pharmaceutical market invests worldwide just more than ten percent of its research effort in this field.
DNDi operates globally through a number of private and public partnerships in more than 40 countries – including 50 public research centres and 20 pharmaceutical and biotech companies. DNDi supports health staff and doctors at several clinical research facilities with treatments and diagnostic tools.
Pascal Carpentier, DNDi Head of Information Systems and Technologies: „We use PowerFolder to collect microscope videos and photos taken in our hospitals in the Democratic Republic of the Congo, to find possible indications of an infection with the sleeping sickness“. It often involves large amounts of data, which must be sent as soon as possible, in a safe and especially reliable way. For Pascal Carpentier, PowerFolder is the best solution. „Our network is based on satellite links. PowerFolder – with its compression and block-transfer – allows us an extremely safe and cost-effective data transmission. Due to the high sensitivity of the patient data only a private cloud solution is possible. We are very pleased with PowerFolder. In future we will also plan to use it in Africa and Latin America.“
The Drugs for Neglected Diseases initiative (DNDi) was established in Geneva in 2003 by renowned research and health organizations such as Doctors Without Borders (MSF) or the Institut Pasteur. The organization is active in research and development of affordable drugs for neglected diseases through partnerships with the public and private sectors (universities, research institutes, pharmaceutical companies, etc). DNDi aims to improve the quality of life and health of people suffering from these diseases – by an alternative model for drug development and by ensuring equal access to new and adapted therapies to patients in need. DNDi is funded by governments, private foundations, and individual donors.
You must be logged in to post a comment Login